15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1α

European Journal of Clinical Investigation

Volumn 40, Issue 1, 2010, Pages 11-17

  Hulten L M ^a,b   Olson, F J ^a,b   Aberg H ^a,b   Carlsson, J ^a,b   Karlstrom L ^a   Boren J ^a,b   Fagerberg, B ^a,b   Wiklund, O ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

15 lipoxygenase 2; Carotid plaques; Human; Hypoxia; Macrophages

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 15 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE 2; CD68 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; SMOOTH MUSCLE FIBER; STAINING; TISSUE SECTION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ARACHIDONATE 15-LIPOXYGENASE; CAROTID STENOSIS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 74049111313     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02223.x     Document Type: Article

References (31)

1. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001 104 : 503 516.
2. Gustafsson M, Flood C, Jirholt P, Boren J. Retention of atherogenic lipoproteins in atherogenesis. Cell Mol Life Sci 2004 61 : 4 9.
3. Virella G, Lopes-Virella MF. Atherogenesis and the humoral immune response to modified lipoproteins. Atherosclerosis 2008 200 : 239 246.
4. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and Atherosclerosis. Annu Rev Pathol Mech Dis 2006 1 : 297 329.
5. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008 51 : 1258 1265.
6. Rydberg EK, Salomonsson L, Hulten LM, Noren K, Bondjers G, Wiklund O et al. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis 2003 170 : 245 252.
7. Bostrom P, Magnusson B, Svensson PA, Wiklund O, Boren J, Carlsson LM et al. Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol 2006 26 : 1871 1876.
8. Kuhn H, O'Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 2006 45 : 334 356.
9. Ezaki M, Witztum JL, Steinberg D. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J Lipid Res 1995 36 : 1996 2004.
10. Kuhn H, Belkner J, Suzuki H, Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res 1994 35 : 1749 1759.
11. Yla-Herttuala S, Luoma J, Viita H, Hiltunen T, Sisto T, Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995 95 : 2692 2698.
12. Hedrick CC, Kim MD, Natarajan RD, Nadler JL. 12-Lipoxygenase products increase monocyte:endothelial interactions. Adv Exp Med Biol 1999 469 : 455 460.
13. Waddington E, Sienuarine K, Puddey I, Croft K. Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography. Anal Biochem 2001 292 : 234 244.
14. Funk CD, Cyrus T. 12/15-lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med 2001 11 : 116 124.
15. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000 20 : 2100 2105.
16. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999 103 : 1597 1604.
17. Nunemaker CS, Chen M, Pei H, Kimble SD, Keller SR, Carter JD et al. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by western diet. Am J Physiol Endocrinol Metab 2008 295 : E1065 75.
18. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kuhn H et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996 98 : 2201 2208.
19. Brash AR, Boeglin WE, Chang MS. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 1997 94 : 6148 6152.
20. Rydberg EK, Krettek A, Ullstrom C, Ekstrom K, Svensson PA, Carlsson LM et al. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler Thromb Vasc Biol 2004 24 : 2040 2045.
21. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991 337 : 1235 1243.
22. Mattsson L, Bondjers G, Wiklund O. Isolation of cell populations from arterial tissue, using monoclonal antibodies and magnetic microspheres. Atherosclerosis 1991 89 : 25 34.
23. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001 292 : 468 472.
24. Svensson PA, Olson FJ, Hagg DA, Ryndel M, Wiklund O, Karlstrom L et al. Urokinase-type plasminogen activator receptor is associated with macrophages and plaque rupture in symptomatic carotid atherosclerosis. Int J Mol Med 2008 22 : 459 464.
25. Waldo SW, Li Y, Buono C, Zhao B, Billings EM, Chang J et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 2008 172 : 1112 1126.
26. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008 117 : 1649 1657.
27. Danielsson KN, Rydberg EK, Ingelsten M, Akyurek LM, Jirholt P, Ullstrom C et al. 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. Atherosclerosis 2008 199 : 34 40.
28. Wittwer J, Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007 77 : 67 77.
29. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003 100 : 1238 1243.
30. Ruas JL, Lendahl U, Poellinger L. Modulation of vascular gene expression by hypoxia. Curr Opin Lipidol 2007 18 : 508 514.
31. Vink A, Schoneveld AH, Lamers D, Houben AJ, van der Groep P, van Diest PJ et al. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis 2007 195 : e69 75.